Physician

Alan D. Deutsch, D.O.

According to 2025 Medicare claims, Alan Deutsch, D.O. (NPI: 1528040011) practices neurology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Ocean, NJ. This provider's primary affiliated billing organization is MONMOUTH-OCEAN NEUROLOGY PC (NPI: 1508848599; TIN: 223312272) and primary practice location at 08724-7728.

Deutsch's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 603 traditional Medicare patients, billed 1,192 HCPCS/CPT codes, and received $126,933 in Medicare payments. The top billing code was 95816 (Measurement of brain wave activity (eeg), awake and drowsy). Part D data shows 3,293 prescription claims across 543 beneficiaries totaling $2,167,278 in drug costs, led by Ultomiris (Ravulizumab-Cwvz). 2020 DME data shows 11 claims. Open Payments data shows 160 records totaling $2,459. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $884,153 to $2,167,278. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $2,797 to $736.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,143	2,941	$260,299
2016	1,199	2,856	$225,807
2017	1,068	2,623	$217,346
2018	1,100	2,813	$237,619
2019	1,092	2,705	$247,887
2020	981	2,396	$240,773
2021	1,113	2,700	$280,520
2022	954	2,359	$240,384
2023	826	1,889	$202,284
2024	603	1,192	$126,933

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	390	2,948	$884,153
2016	396	3,029	$667,593
2017	419	3,120	$814,434
2018	458	3,409	$1,117,837
2019	459	3,345	$1,600,141
2020	485	3,369	$2,168,945
2021	482	3,394	$2,728,105
2022	510	3,370	$2,488,333
2023	514	3,161	$1,921,603
2024	543	3,293	$2,167,278

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$758
2016	N/R	N/R	N/R
2017	N/R	11	$378
2018	N/R	25	$610
2019	N/R	11	$655
2020	N/R	11	$586
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95816	Measurement of brain wave activity (eeg), awake and drowsy	67	67	$337
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	56	64	$145
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	123	123	$126
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	310	464	$100
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	140	169	$69

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ultomiris	Ravulizumab-Cwvz	13	364	$904,102
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	34	756	$364,170
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	14	371	$169,795
Fingolimod	Fingolimod Hcl	12	360	$86,614
Aptiom	Eslicarbazepine Acetate	19	604	$36,030

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	160	$2,459	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alan D. Deutsch, D.O.?

Tedicare shows public-source Medicare data for Alan D. Deutsch, D.O. (NPI 1528040011), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan D. Deutsch, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alan D. Deutsch, D.O.?

Alan D. Deutsch, D.O. is linked to MONMOUTH-OCEAN NEUROLOGY PC (billing NPI 1508848599) in the available physician profile data.

Does Alan D. Deutsch, D.O. have Open Payments data?

Alan D. Deutsch, D.O. has 160 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.